Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Net Margin (2016 - 2026)

Healthequity has reported Net Margin over the past 14 years, most recently at 14.87% for Q1 2026.

  • Quarterly results put Net Margin at 14.87% for Q1 2026, up 641.0% from a year ago — trailing twelve months through Jan 2026 was 16.39% (up 833.0% YoY), and the annual figure for FY2026 was 16.38%, up 832.0%.
  • Net Margin for Q1 2026 was 14.87% at Healthequity, down from 16.06% in the prior quarter.
  • Over the last five years, Net Margin for HQY hit a ceiling of 18.37% in Q3 2025 and a floor of 16.14% in Q1 2022.
  • Median Net Margin over the past 5 years was 5.89% (2023), compared with a mean of 5.36%.
  • Biggest five-year swings in Net Margin: plummeted -1900bps in 2022 and later surged 1605bps in 2023.
  • Healthequity's Net Margin stood at 0.76% in 2022, then soared by 875bps to 5.89% in 2023, then plummeted by -68bps to 1.9% in 2024, then soared by 746bps to 16.06% in 2025, then fell by -7bps to 14.87% in 2026.
  • The last three reported values for Net Margin were 14.87% (Q1 2026), 16.06% (Q4 2025), and 18.37% (Q3 2025) per Business Quant data.